Inhibitors of inosine monophosphate dehydrogenase as potential chemotherapeutic agents
- 1 January 1999
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 9 (1), 55-65
- https://doi.org/10.1517/13543776.9.1.55
Abstract
Inosine monophosphate dehydrogenase (IMPDH), an NAD-dependent enzyme which controls de novo synthesis of purine nucleotides, is an important target for the development of chemotherapeutic agents. The concentration of IMPDH was found to increase in tumour cells and activated lymphocytes. Thus, inhibition of IMPDH would result in anticancer and immunosuppressive activities. Since there is an increased demand for purine nucleotides in virus infected cells needed for RNA and DNA synthesis, inhibition of IMPDH may also lead to antiviral activity. IMPDHs from bacteria, parasites and mammalian sources differ significantly. Such differences can be exploited for the development of antibacterial or antiparasitic agents. Recent progress in revealing the molecular structure, mechanism of action and interactions of the enzyme with the co-factor and inhibitors provided a new stimulus for the development of novel agents targeted against IMPDH. This review covers both academic and industrial studies aimed at inhibition of IMPDH.Keywords
This publication has 15 references indexed in Scilit:
- Synthesis of a Methylenebis(phosphonate) Analogue of Mycophenolic Adenine Dinucleotide: A Glucuronidation-Resistant MAD Analogue of NADJournal of Medicinal Chemistry, 1998
- The Roles of Conserved Carboxylate Residues in IMP Dehydrogenase and Identification of a Transition State AnalogBiochemistry, 1997
- Kinetic Mechanism of Human Inosine 5‘-Monophosphate Dehydrogenase Type II: Random Addition of Substrates and Ordered Release of ProductsBiochemistry, 1997
- Synthesis, Structure, and Antiproliferative Activity of Selenophenfurin, an Inosine 5‘-Monophosphate Dehydrogenase Inhibitor Analogue of SelenazofurinJournal of Medicinal Chemistry, 1997
- Rationally Designed Inhibitors of Inosine Monophosphate DehydrogenaseJournal of Medicinal Chemistry, 1997
- Inactivation of Inosine 5‘-Monophosphate Dehydrogenase by the Antiviral Agent 5-Ethynyl-1-β-d-Ribofuranosylimidazole-4-Carboxamide 5‘-MonophosphateBiochemistry, 1996
- Antiviral Activities of Mizoribine and other Inosine Monophosphate Dehydrogenase Inhibitors against Several Ortho- and ParamyxovirusesAntiviral Chemistry and Chemotherapy, 1994
- Mycophenolate mofetil: Molecular mechanisms of actionPerspectives in Drug Discovery and Design, 1994
- Synthesis and cytotoxic activity of C-glycosidic nicotinamide riboside analogsJournal of Medicinal Chemistry, 1992
- Nucleosides and nucleotides. 96. Synthesis and antitumor activity of 5-ethynyl-1-.beta.-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivativesJournal of Medicinal Chemistry, 1991